1. Home
  2. SILO vs SPHL Comparison

SILO vs SPHL Comparison

Compare SILO & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • SPHL
  • Stock Information
  • Founded
  • SILO 2010
  • SPHL 2002
  • Country
  • SILO United States
  • SPHL Singapore
  • Employees
  • SILO N/A
  • SPHL N/A
  • Industry
  • SILO Apparel
  • SPHL Homebuilding
  • Sector
  • SILO Consumer Discretionary
  • SPHL Consumer Discretionary
  • Exchange
  • SILO Nasdaq
  • SPHL Nasdaq
  • Market Cap
  • SILO 5.9M
  • SPHL 4.9M
  • IPO Year
  • SILO N/A
  • SPHL 2024
  • Fundamental
  • Price
  • SILO $0.69
  • SPHL $0.62
  • Analyst Decision
  • SILO
  • SPHL
  • Analyst Count
  • SILO 0
  • SPHL 0
  • Target Price
  • SILO N/A
  • SPHL N/A
  • AVG Volume (30 Days)
  • SILO 289.1K
  • SPHL 2.7M
  • Earning Date
  • SILO 08-13-2025
  • SPHL 01-01-0001
  • Dividend Yield
  • SILO N/A
  • SPHL N/A
  • EPS Growth
  • SILO N/A
  • SPHL N/A
  • EPS
  • SILO N/A
  • SPHL N/A
  • Revenue
  • SILO $72,102.00
  • SPHL $6,456,601.00
  • Revenue This Year
  • SILO $1.86
  • SPHL N/A
  • Revenue Next Year
  • SILO N/A
  • SPHL N/A
  • P/E Ratio
  • SILO N/A
  • SPHL N/A
  • Revenue Growth
  • SILO N/A
  • SPHL N/A
  • 52 Week Low
  • SILO $0.41
  • SPHL $0.35
  • 52 Week High
  • SILO $3.37
  • SPHL $7.80
  • Technical
  • Relative Strength Index (RSI)
  • SILO 55.60
  • SPHL 59.58
  • Support Level
  • SILO $0.58
  • SPHL $0.37
  • Resistance Level
  • SILO $0.65
  • SPHL $0.87
  • Average True Range (ATR)
  • SILO 0.04
  • SPHL 0.08
  • MACD
  • SILO 0.00
  • SPHL 0.02
  • Stochastic Oscillator
  • SILO 83.31
  • SPHL 43.23

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.

Share on Social Networks: